Improving methods for delivering treatments to cells without contact
High-Precision Non-Contact Plasmon-Induced Intracellular Delivery
This study is exploring new ways to deliver treatments directly into cells without touching them, which could make gene therapy and other treatments work better for patients, while also supporting a diverse group of researchers in the process.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Houston NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10813943 on NIH RePORTER |
What this research studies
This research focuses on developing advanced techniques for delivering therapeutic agents directly into cells without physical contact. By utilizing plasmon-induced methods, the research aims to enhance the precision and effectiveness of gene therapy and other treatments at the cellular level. Patients may benefit from improved delivery methods that could lead to better treatment outcomes for various conditions. The research also emphasizes training and mentorship for underrepresented researchers, fostering a more diverse scientific community.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with genetic disorders or conditions that could benefit from advanced gene therapy techniques.
Not a fit: Patients with conditions that do not involve cellular therapies or genetic interventions may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and targeted treatments for patients with genetic disorders and other conditions requiring cellular intervention.
How similar studies have performed: Other research has shown promise in using non-contact methods for cellular delivery, indicating potential for success in this novel approach.
Where this research is happening
Houston, United States
- University of Houston — Houston, United States (Active)
Researchers
- Principal investigator: Chiang, Naihao — University of Houston
- Study coordinator: Chiang, Naihao
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.